Preventing blindness due to diabetic retinopathy: Control glycaemia and blood pressure, and monitor the eyes

Prescrire International

Volumn 19, Issue 105, 2010, Pages 35-38

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; VASCULOTROPIN INHIBITOR;

BLINDNESS; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LASER COAGULATION; LOW LEVEL LASER THERAPY; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; REVIEW; RISK BENEFIT ANALYSIS; VISUAL ACUITY;

BLINDNESS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMANS; MONITORING, PHYSIOLOGIC; VISUAL ACUITY;

EID: 76549084143     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Institut de veille sanitaire "Résultats épidé miologiques principaux d'Entred-métropole" 17 March 2009. www.invs.sante.fr accessed 3 July 2009: 6 pages.
2. Prescrire Rédaction "Prévenir et traiter la rétinopathie diabétique" Rev Prescrire 1995; 15 (148): 114-123.
3. Mohamed Q et al. "Management of diabetic retinopathy. A systematic review" JAMA 2007; 298 (8): 902-916.
4. Prescrire Editorial Staff "Prevention of complications of insulin-dependent diabetes mellitus by intensive insulin therapy" Prescrire Int 1994; 3 (13): 158.
5. Prescrire Rédaction "Réduction de la microangiopathie diabétique par l'intensification de l'insulinothérapie (suite)" Rev Prescrire 1998; 18 (180): 60-61.
6. Prescrire Rédaction "Traitement des diabétiques de type 2 (non insulinodépendants): enfin des résultats cliniques en faveur du contrôle de la glycémie" Rev Prescrire 1999; 19 (196): 448-456 + (197): 560.
7. The ADVANCE collaborative group "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes" N Engl J Med 2008; 358: 2560-2572.
8. Prescrire Editorial Staff "Type 2 diabetes and HbA1c targets" Prescrire Int 2008; 17 (98): 254.
9. Prescrire Rédaction "Aggravation paradoxale de la rétinopathie diabétique liée à la normalisation glycémique" Rev Prescrire 2000; 20 (204): 219.
10. Prescrire Editorial Staff "Adult hypertension: reducing cardiovascular morbidity and mortality" Prescrire Int 2004; 13 (75): 25-33.
11. Massin P "Rétinopathie diabétique". In: Grimaldi A "Traité de diabétologie" Médecine-Sciences Flammarion, Paris 2005: 536-551.
12. Meyer CH "Current treatment approaches in diabetic macular edema" Ophthalmologica 2007; 221 (2): 118-131.
13. Grover DA et al. "Intravitreal steroids for macular edema in diabetes" (Cochrane Review) (last update 2008) John Wiley and Sons, Chichester 2009; issue 2: 43 pages.
14. Diabetic retinopathy clinical research network et al. "Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema" Arch Ophthalmol 2009; 127 (3): 245-251.
15. Yilmaz T et al. "Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review" Ophthalmology 2009; 116 (5): 902-911.
16. Elman MJ et al. "A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema" Ophthalmology 2008; 115 (9): 1447-1449.
17. Soheilian M et al. "Randomized trial of intravitreal bevadzumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema" Ophthalmology 2009; 116 (6): 1142-1150.
18. Prescrire Editorial Staff "Managing type 2 diabetes" Prescrire Int 2001; 10: (55): 158.
19. Chaturvedi N et al. "Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised placebo-controlled trials" Lancet 2008; 372: 1394-1402.
20. Sjølie AK et al. "Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial" Lancet 2008; 372: 1385-1393.
21. Mauer M et al. "Renal and retinal effects of enalapril and losartan in type 1 diabetes" N Engl J Med 2009; 361 (1): 40-51.